US Patent 10246709 Targeting ligands for therapeutic compounds
Patent 10246709 was granted and assigned to Arrowhead Pharmaceuticals, Inc. on April, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 7, 2017
Date of Patent
April 2, 2019
Patent Applicant
Patent Application Number
15452423
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10246709 Targeting ligands for therapeutic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.